James Russell
Corporate Officer/Principal presso University of British Columbia
Profilo
Mr. James Russell is Co-Founder at Sirius Genomics, Inc., a Professor at University of British Columbia, and an Associate Director-Intensive Care Unit at St. Paul's Hospital.
He received his doctorate degree from the University of Toronto.
Posizioni attive di James Russell
| Società | Posizione | Inizio |
|---|---|---|
| University of British Columbia | Corporate Officer/Principal | 13/11/2009 |
St. Paul's Hospital
 St. Paul's Hospital Hospital/Nursing ManagementHealth Services St. Paul's Hospital operates a medical hospital. The private company is based in Hong Kong, Hong Kong. | Corporate Officer/Principal | - |
Precedenti posizioni note di James Russell
| Società | Posizione | Fine |
|---|---|---|
Sirius Genomics, Inc.
 Sirius Genomics, Inc. Pharmaceuticals: MajorHealth Technology Sirius Genomics, Inc. develops DNA-based diagnostic and pharmacogenetic products. Its product is Sepsis. It also develops companion diagnostics, that are closely tied to therapeutic decisions, leading to better patient outcomes through personalized medicine. Sirius generates value by improving the safety and effectiveness of pharmaceutical compounds. The company correlates patient genetics with clinical outcomes, leading to proprietary and commercially viable CDx products. Sirius Genomics was founded by James A. Russell and Keith Walley in 2001 and is headquartered in Vancouver, Canada. | Fondatore | - |
Formazione di James Russell
| University of Toronto | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Sirius Genomics, Inc.
Sirius Genomics, Inc. Pharmaceuticals: MajorHealth Technology Sirius Genomics, Inc. develops DNA-based diagnostic and pharmacogenetic products. Its product is Sepsis. It also develops companion diagnostics, that are closely tied to therapeutic decisions, leading to better patient outcomes through personalized medicine. Sirius generates value by improving the safety and effectiveness of pharmaceutical compounds. The company correlates patient genetics with clinical outcomes, leading to proprietary and commercially viable CDx products. Sirius Genomics was founded by James A. Russell and Keith Walley in 2001 and is headquartered in Vancouver, Canada. | Health Technology |
St. Paul's Hospital
St. Paul's Hospital Hospital/Nursing ManagementHealth Services St. Paul's Hospital operates a medical hospital. The private company is based in Hong Kong, Hong Kong. | Health Services |
- Borsa valori
- Insiders
- James Russell
